IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
May 11, 2022
Salt Lake City, UT, May 10, 2022 – IONIQ Sciences is humbled to be recognized with three separate awards from ‘Global 100‘ especially during ‘Lung Cancer Hope Month.’ These three awards and earlier designation by the US FDA as a ‘Breakthrough Device‘ is further validation of our growing clinical evidence library from seven trials at 24 sites with 1.2K subjects and more than 20M data points.
– Best Medical Technology Company 2022
– Most Innovative Non-Invasive Lung Cancer Testing Solution 2022: The IONIQ ProLung Test – USA
– Best Lung Cancer Predictive Analytics Risk Testing Platform: The IONIQ ProLung Test – USA for 2022
Click here to visit Global 100’s magazine to read more about our awards (pgs 10 and 32).
The clinical evidence across cancer types continues to demonstrate that early detection saves money and lives. When cancer can be diagnosed in the earliest and most-treatable stages, survival rates are ~90%. Early detection matters most and IONIQ Sciences is focused on making it a reality with our non-invasive bioimpedance technology.
About IONIQ Sciences, Inc.
IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA. For more information visit: www.IONIQsciences.com
About BioHive
IONIQ Sciences is proud to be a key supporter and member of the newly formed BioHive, a collective representing the life science and healthcare innovation ecosystem. By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America and their innovations are improving the lives of millions of patients. To learn more, visit: www.biohive.com
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com